Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

48 results about "Gentamicin C1a" patented technology

One of the major components of the gentamicin complex. Gentamicin C1a lacks methyl groups on the 2-amino-hexose ring and has a free amine at the 6' position.

Technological method for producing gentamicin C1a through fermentation

PendingCN106801076AImprove metabolism and synthesis abilityIncrease productionBacteriaMicroorganism based processesSporeBiotechnology
The invention relates to a technological method for producing gentamicin C1a through fermentation, and belongs to the technical field of fermentation engineering. The technological method for producing gentamicin C1a through fermentation comprises the following concentrated technological means: spore culture, seed liquid preparation, primary seed culture, secondary seed culture, fermentation production and material supplementation control, wherein components and proportions of a primary seed culture medium, a secondary seed culture medium and a fermentation culture medium are mainly provided by the technological method; meanwhile, in the material supplementation control stage, sugar supplementing, water supplementing, defoamer supplementing, alkali supplementing and nitrogen supplementing operations are performed, and the material supplementing time, the material supplementing components and the material supplementing amount are controlled. The technological method is achieved by relying on culture media for producing the gentamicin C1a through efficient and low-cost fermentation, and in the fermentation process, technological control is performed, so that the fermentation titer unit is improved and the yield is increased by 43%; meanwhile, the production cost is reduced to the maximum extent; therefore, the technological method is very practical during production of the gentamicin C1a.
Owner:HENAN RENHUA BIOTECH CO LTD

Synthesis method of 6''-N-ethyl gentamicin C1a

The invention relates to a synthesis method of 6''-N-ethyl gentamicin C1a. The synthesis method of the 6''-N-ethyl gentamicin C1a comprises the following steps that (1) a compound 1 gentamicin C1a isdissolved in a solvent for cooling, BOC-ON is added and stirred, and water and ethyl acetate are added to be subjected to liquid separating, water phase taking, and condensing to obtain a compound 2;(2) a concentrated solution is dissolved by methanol, triethylamine is added for cooling, and acetic anhydride is added, stirred and condensed to remove a solvent; (3) hydrochloric acid is added to aconcentrated solution, and stirred at the room temperature, pH is adjusted by a sodium hydroxide solution for concentration, and a compound 3, namely 1,3,2''-N,N,N-triacetyl gentamicin C1a is obtainedby purification and separation through a silica gel column; and (4) after the 1,3,2''-N,N,N-tracetyl gentamicin C1a, glycol dimethyl ether, hexamethyldisilazane and a concentrated sulfuric acid are mixed and heated until refluxing and dissolving, stirring and concentrating continue to be conducted to remove the solvent so as to obtain a compound 4, dichloromethane is added for cooling, acetaldehyde is added to be stirred, potassium borohydride is added to be stirred, a borate buffer solution is added to be stirred, sodium hydroxide is added for condensing and removing the dichloromethane, thesodium hydroxide is added for heating and refluxing, and macroporous resin is subjected to desalination and separation to obtain a compound 5, namely 6''-N- ethyl gentamicin C1a.
Owner:WUXI JIYU SHANHE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products